Fig. 1
From: MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC
Association between acquired MRE11:p.K464R mutation and the prognosis of ovarian cancer patients. (A) The distribution of MRE11:p.K464R mutation content (cfDNA) and PFS in patients. (B) Survival analysis of acquired MRE11:p.K4 mutation in patients. (C) The variations of MRE11 in four serous ovarian cancer datasets of cBioportal database. (D) The distribution of MRE11 mutation types in four serous ovarian cancer datasets. (E) The distribution of MRE11 mutation types in this study